Dr. Engelking completed undergraduate studies in biochemistry at Texas A&M University (1996-2000), joint MD/PhD training (2000-2007) at UT Southwestern in Dallas, where he studied cholesterol metabolism under Nobel Laureates Goldstein and Brown. He then completed clinical training at Massachusetts General Hospital (2007-2010), an affiliate of Harvard Medical School, and then returned to UT Southwestern for clinical and research fellowship in gastroenterology (2010-2014). He is a teaching gastroenterologist and serves as the director of the Hereditary GI Cancer Clinic. His laboratory focuses on lipid metabolism in the GI tract and in GI cancers.
Title : SREBPs in the control of intestinal homeostasis and tumorigenesis